Fenofibrate is used for: Hyperlipidemia; Hypercholesterolaemia; Hypertriglyceridaemia.
Recorded in the NepalDoc medicine catalog for Fenofibrate.
Fenofibrate tablet USP is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as an adjunct to diet: To reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia. For treatment of adult patients with severe hypertriglyceridemia.
From the U.S. FDA-approved label for Fenofibrate. Full label: DailyMed.
Fenofibrate tablet USP is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as an adjunct to diet: To reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia. For treatment of adult patients with severe hypertriglyceridemia.
From the U.S. FDA-approved label for Fenofibrate. Full label: DailyMed.
Primary hypercholesterolemia or mixed dyslipidemia: Initial dose of 160 mg once daily. Severe hypertriglyceridemia: Initial dose of 54 to 160 mg once daily. Maximum dose is 160 mg.
Directions from the U.S. FDA-approved label for Fenofibrate — your doctor or pharmacist may advise differently.
Severe renal dysfunction, including dialysis patients. Active liver disease. Gallbladder disease. Known hypersensitivity to fenofibrate. Nursing mothers. Fenofibrate is contraindicated in: patients with severe renal impairment, including those receiving dialysis. patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities. patients with preexisting gallbladder disease. nursing mothers patients with known hypersensitivity to fenofibrate or fenofibric acid.
Excerpt from the U.S. FDA-approved label for Fenofibrate. Talk to a pharmacist or doctor before use.
Hepatotoxicity: Serious drug-induced liver injury, including liver transplantation and death, has been reported with fenofibrate. Monitor patient's liver function, including serum ALT, AST, and total bilirubin, atbaseline and periodically for the duration of therapy. Discontinue if signs or symptoms of liver injury develop or if elevated enzyme levels persist. Myopathy and rhabdomyolysis: Have been reported in patients taking fenofibrate.
Warnings and precautions excerpt from the U.S. FDA-approved label for Fenofibrate — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are described below and elsewhere in the labeling: Mortality and coronary heart disease morbidity,Hepatoxicity,Pancreatitis,Hypersensitivity reactions, Venothromboembolic disease Adverse reactions > 2% and at least 1% greater than placebo: Abnormal liver tests, increased AST, increased ALT, increased CPK, and rhinitis.
Excerpt from the U.S. FDA-approved label for Fenofibrate — not a complete list. Talk to a pharmacist or doctor about side effects.
7 brands · 6 makers in the NepalDoc catalog — see the full Fenofibrate guide →
What is Fenolip?
Fenolip 145mg Tablet is a Fenofibrate medicine made by Cipla Ltd. It comes as 145mg Tablet.
What is Fenolip used for?
Fenofibrate is used for Hyperlipidemia, Hypercholesterolaemia, Hypertriglyceridaemia.
What is the generic name of Fenolip?
The generic name of Fenolip is Fenofibrate.
Which brands of Fenofibrate are available in Nepal?
7 brands of Fenofibrate are listed in the NepalDoc catalog, from 6 makers — including Fenocard 160mg Tablet, Fenorate 160mg Tablet, Finorate 160mg Tablet, Lipicard 200mg Capsule, Stanlip 145mg Tablet, Tgr 160mg Tablet.
What are the side effects of Fenofibrate?
The following serious adverse reactions are described below and elsewhere in the labeling: Mortality and coronary heart disease morbidity,Hepatoxicity,Pancreatitis,Hypersensitivity reactions, Venothromboembolic disease Adverse reactions > 2% and at least 1% greater than placebo: Abnormal liver tests, increased AST, increased ALT, increased CPK, and rhinitis.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
